Vischer advised globally active asset manager Blue Owl on an up to USD 500 million term loan facility for Madrigal Pharmaceuticals, a biopharmaceutical company specialised in therapeutics for metabolic dysfunction-associated steatohepatitis. The Vischer team Adrian Dö
Tags :sx1
Kevin M. Hubacher (pictured) is Vischer’s latest partnership addition, effective October 1, 2025. The profile Moving from MLL Legal, Hubacher is an expert in M&A/private equity transactions, venture capital investments, restructurings and corporate
Homburger advised Santhera in connection with its CHF 20 m royalty monetization and convertible bond financing. The deal encompassed an USD 13 m royalty monetization financing with R-Bridge, an affiliate of Singapore-based healthcare-focused investment firm CBC Group.
Lenz & Staehelin has successfully defended Swiss telecom provider Swisscom, in a competition law investigation. The context The investigation pivoted around the case by which Swisscom had charged too high prices in various tenders for
Lenz & Staehelin advised BNP Paribas on the Swiss merger filing concerning BNP Paribas Cardif’s acquisition of AXA Investment Managers (AXA IM). BNP Paribas Cardif is the insurance subsidiary of BNP Paribas. The transaction,
Niederer Kraft Frey advised aerospace company SWISSto12 on the acquisition of key assets and IP from Hanwha Phasor, following the latter’s liquidation. The parties Headquartered in Renens, SWISSto12 is an original equipment manufacturer (OEM)
Homburger advised RV AIP S.C.S. SICAV-SIF – RV TF Acquisition Financing in connection with its role as lender for the EUR 31m credit financing of European AV Group. The Homburger team Daniel Haeberli (financing,
Homburger advised UBS Group on the issuance of €2 billion in fixed-rate, fixed-rate callable senior notes under its Senior Debt Programme. The issuance The operation was split into two tranches: €1.25 billion maturing in 2036 and €750 million maturing
MLL Legal advised Previse Systems on its recent growth investment round. In connection with the deal, the company secured growth capital from global growth equity platform Lightrock. Headquartered in Zug, Previse Systems is an ETRM
Kellerhals Carrard advised Comphya, a medtech spin-off from EPFL Lausanne, throughout closing the second tranche of a CHF 7.5 million Series A financing round. The context Comphya will destine the proceeds toward growing the project of
